D. Scott Neal’s Zimmer Biomet ZBH Stock Holding History

D. Scott Neal’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-34	Closed	-$4K	–	189
2017 Q1	$4K	Hold	34	–	–	﹤0.01%	142
2016 Q4	$3K	Hold	34	–	–	﹤0.01%	147
2016 Q3	$4K	Hold	34	–	–	﹤0.01%	138
2016 Q2	$4K	Buy	+34	New	+$3.85K	﹤0.01%	138

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D. Scott Neal's ZBH Position: Q2 2017 in Review

D. Scott Neal sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 34 shares — an estimated $4K sold.

D. Scott Neal first reported a position in ZBH in Q2 2016 and held it in 4 quarters. The position peaked at $4K in Q1 2017. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

D. Scott Neal reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
D. Scott Neal sold 34 Zimmer Biomet shares in Q2 2017, an estimated $4K.
D. Scott Neal first reported a position in Zimmer Biomet in Q2 2016 and held it in 4 quarters.
D. Scott Neal's Zimmer Biomet position peaked at $4K in Q1 2017.
819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on D. Scott Neal's 13F filing for Q2 2017, filed 14 Jul 2017.